Buys
Open market- Shares
- Avg price
- Total value
Gregory R. Friberg - EVP, Chief R&D Officer at BIOMARIN PHARMACEUTICAL INC
Issuer-level insider activity
- Role
- EVP, Chief R&D Officer
- Issuer ticker
- BMRN on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Gregory R. Friberg in BIOMARIN PHARMACEUTICAL INC
Sells
Open market- Shares
- -9,607
- Avg price
- $58.15
- Total value
- -$558,619
Net
Past year- Shares
- -9,607
- Share %
- -100%
- Total value
- -$558,619
Reported holdings for Gregory R. Friberg in BIOMARIN PHARMACEUTICAL INC
Form 4 holding
EVP, Chief R&D Officer
BIOMARIN PHARMACEUTICAL INC
- Security class
- Common Stock
- Shares / value
- 51,818
- Estimated value
- $2,790,399
- Report date
- 07 May 2026
- Price
- $53.85
- Ownership
- Direct
Form 4 holding
EVP, Chief R&D Officer
BIOMARIN PHARMACEUTICAL INC
- Security class
- Stock Option (Right to Buy Common Stock)
- Shares / value
- 45,600
- Estimated value
- Report date
- 16 Mar 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Gregory R. Friberg in BIOMARIN PHARMACEUTICAL INC
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.